Diagnostica Stago Inc:企業の製品パイプライン分析2018

◆英語タイトル:Diagnostica Stago Inc - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C8807
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Diagnostica Stago Inc (Stago), a subsidiary of Diagnostica Stago SAS, is a medical device company that develops and distributes in-vitro diagnostic products. The company develops coagulation automation systems. It provides products such as hemostasis analyzers, viscosity based detection systems, reagents and research products. Stago’s research and reagent products includes venoms, activators, purified proteins, coagulation factors, inhibitors, chromogenic substrates, lupus inhibitors, heparin anti-xa assays, coagulation inhibitors, fibrin and fibrinogen degradation products, among others. The company offers various customer services such as proficiency testing, field technical support, education and customer training. It also offers hemostasis proficiency testing program and peer group program. The company operates in the US and Canada. Stago is headquartered in Parsippany, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Diagnostica Stago Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Diagnostica Stago Inc Company Overview 5
Diagnostica Stago Inc Company Snapshot 5
Diagnostica Stago Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Diagnostica Stago Inc – Pipeline Analysis Overview 7
Diagnostica Stago Inc – Key Facts 7
Diagnostica Stago Inc – Major Products and Services 8
Diagnostica Stago Inc Pipeline Products by Development Stage 9
Diagnostica Stago Inc Pipeline Products Overview 11
Calibrated Automated Thrombogram – Thrombin Assay 11
Calibrated Automated Thrombogram – Thrombin Assay Product Overview 11
STA Compact Max – Apixaban Calibrators And Controls 12
STA Compact Max – Apixaban Calibrators And Controls Product Overview 12
STA Compact Max – Dabigatran Calibrator And Control 13
STA Compact Max – Dabigatran Calibrator And Control Product Overview 13
STA Compact Max – Edoxaban Calibrator And Control 14
STA Compact Max – Edoxaban Calibrator And Control Product Overview 14
STA Compact Max – NeoPTimal ISI 15
STA Compact Max – NeoPTimal ISI Product Overview 15
STA Compact Max – Ristocetin Cofactor Assay 16
STA Compact Max – Ristocetin Cofactor Assay Product Overview 16
STA Compact Max – Rivaroxaban Calibrators And Controls For Anti-Xa 17
STA Compact Max – Rivaroxaban Calibrators And Controls For Anti-Xa Product Overview 17
STA-R Evolution Expert – Automated Ecarin Chromogenic Assay 18
STA-R Evolution Expert – Automated Ecarin Chromogenic Assay Product Overview 18
STA-R Evolution Expert – Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa 19
STA-R Evolution Expert – Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa Product Overview 19
STA-R Evolution Plus – Automated Ecarin Chromogenic Assay 20
STA-R Evolution Plus – Automated Ecarin Chromogenic Assay Product Overview 20
STA-R Evolution Plus – Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa 21
STA-R Evolution Plus – Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa Product Overview 21
STA-R Max – Apixaban Calibrators And Controls 22
STA-R Max – Apixaban Calibrators And Controls Product Overview 22
STA-R Max – Dabigatran Calibrator And Control 23
STA-R Max – Dabigatran Calibrator And Control Product Overview 23
STA-R Max – Edoxaban Calibrator And Control 24
STA-R Max – Edoxaban Calibrator And Control Product Overview 24
STA-R Max – NeoPTimal ISI 25
STA-R Max – NeoPTimal ISI Product Overview 25
STA-R Max – Ristocetin Cofactor Assay 26
STA-R Max – Ristocetin Cofactor Assay Product Overview 26
STA-R Max – Rivaroxaban Calibrators And Controls For Anti-Xa 27
STA-R Max – Rivaroxaban Calibrators And Controls For Anti-Xa Product Overview 27
Diagnostica Stago Inc – Key Competitors 28
Diagnostica Stago Inc – Key Employees 29
Diagnostica Stago Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Diagnostica Stago Inc, Recent Developments 31
Sep 16, 2014: Stago’s D-Dimer test, 1st assay to meet the new CLSI H59-A standards for exclusion of PE 31
Aug 18, 2009: Diagnostica Stago Opens New Training Center 31
May 04, 2009: Instrumentation Laboratory Wins Patent Infringement And Unfair Competition Trial Against Diagnostica Stago Relating To Reagents For Hemostasis Diagnostics 31
Appendix 33
Methodology 33
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Diagnostica Stago Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Diagnostica Stago Inc Pipeline Products by Equipment Type 6
Diagnostica Stago Inc Pipeline Products by Indication 6
Diagnostica Stago Inc, Key Facts 7
Diagnostica Stago Inc, Major Products and Services 8
Diagnostica Stago Inc Number of Pipeline Products by Development Stage 9
Diagnostica Stago Inc Pipeline Products Summary by Development Stage 10
Calibrated Automated Thrombogram - Thrombin Assay - Product Status 11
Calibrated Automated Thrombogram - Thrombin Assay - Product Description 11
STA Compact Max - Apixaban Calibrators And Controls - Product Status 12
STA Compact Max - Apixaban Calibrators And Controls - Product Description 12
STA Compact Max - Dabigatran Calibrator And Control - Product Status 13
STA Compact Max - Dabigatran Calibrator And Control - Product Description 13
STA Compact Max - Edoxaban Calibrator And Control - Product Status 14
STA Compact Max - Edoxaban Calibrator And Control - Product Description 14
STA Compact Max - NeoPTimal ISI - Product Status 15
STA Compact Max - NeoPTimal ISI - Product Description 15
STA Compact Max - Ristocetin Cofactor Assay - Product Status 16
STA Compact Max - Ristocetin Cofactor Assay - Product Description 16
STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status 17
STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description 17
STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status 18
STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description 18
STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 19
STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 19
STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status 20
STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description 20
STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status 21
STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description 21
STA-R Max - Apixaban Calibrators And Controls - Product Status 22
STA-R Max - Apixaban Calibrators And Controls - Product Description 22
STA-R Max - Dabigatran Calibrator And Control - Product Status 23
STA-R Max - Dabigatran Calibrator And Control - Product Description 23
STA-R Max - Edoxaban Calibrator And Control - Product Status 24
STA-R Max - Edoxaban Calibrator And Control - Product Description 24
STA-R Max - NeoPTimal ISI - Product Status 25
STA-R Max - NeoPTimal ISI - Product Description 25
STA-R Max - Ristocetin Cofactor Assay - Product Status 26
STA-R Max - Ristocetin Cofactor Assay - Product Description 26
STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status 27
STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description 27
Diagnostica Stago Inc, Key Employees 29
Diagnostica Stago Inc, Other Locations 30
Glossary 35

List of Figures
Diagnostica Stago Inc Pipeline Products by Equipment Type 6
Diagnostica Stago Inc Pipeline Products by Development Stage 9

★海外企業調査レポート[Diagnostica Stago Inc:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Probe Scientific Ltd-医療機器分野:企業M&A・提携分析
    Summary Probe Scientific Ltd (Probe Scientific) is a medical device company that develops products to solve clinical issues. The company offers products, which include microeye, continumon and nanoeye, among others. Its microeye is a sampling device for monitoring substances such as electrolytes, am …
  • Medline Industries Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medline Industries Inc (Medline) is one of the leading manufacturers and distributors of healthcare supplies in the US. It distributes products to diverse end users including hospitals, extended care facilities, surgery centers, home care dealers, home care agencies, commercial laundries, ph …
  • Segafredo Zanetti S.p.A.:企業の戦略・SWOT・財務情報
    Segafredo Zanetti S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Segafredo Zanetti S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …
  • Medical & Biological Laboratories Co Ltd (4557)-医療機器分野:企業M&A・提携分析
    Summary Medical & Biological Laboratories Co Ltd (MBL) is a provider of clinical and basic laboratory diagnostics. The company’s products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents for therapeutic areas of allergy, antiphospholipid synd …
  • Abu Dhabi National Hotels Company:企業の戦略・SWOT・財務分析
    Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Star Group LP (SGU):企業の財務・戦略的SWOT分析
    Summary Star Group LP (Star Group) formerly Star Gas Partners LP, is a distributor of home heating products and services. The company distributes and sells heating and air conditioning equipment, diesel fuel, gasoline, propane, and home heating oil. Star Group offers home security and plumbing, inst …
  • Mangalore Refinery and Petrochemicals Ltd (MRPL):企業の財務・戦略的SWOT分析
    Mangalore Refinery and Petrochemicals Ltd (MRPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Monsanto Co (MON):製薬・医療:M&Aディール及び事業提携情報
    Summary Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. It also provides other seed c …
  • Rockwell Medical Inc (RMTI)-製薬・医療分野:企業M&A・提携分析
    Summary Rockwell Medical Inc (Rockwell) is a bio pharmaceutical company focusing on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism; end-stage renal disease (ESRD) and chronic kidney disease. Its major product …
  • Cleco Corporate Holdings LLC:企業の発電所・SWOT分析2018
    Cleco Corporate Holdings LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Gul Ahmed Textile Mills Limited:企業の戦略・SWOT・財務分析
    Gul Ahmed Textile Mills Limited - Strategy, SWOT and Corporate Finance Report Summary Gul Ahmed Textile Mills Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • CellProthera-製薬・医療分野:企業M&A・提携分析
    Summary CellProthera (CellProthera) focuses on the development of therapeutic solutions for the regeneration of organs which are damaged by disease or trauma from autologous blood peripheral stem cells. The company’s lead candidate ProtheraCytes, is an advanced therapy medicinal product within tissu …
  • Omega Pharma NV:企業の戦略・SWOT・財務情報
    Omega Pharma NV - Strategy, SWOT and Corporate Finance Report Summary Omega Pharma NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Yamaha Corporation (7951):企業の財務・戦略的SWOT分析
    Yamaha Corporation (7951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Autolus Therapeutics Plc (AUTL):製薬・医療:M&Aディール及び事業提携情報
    Summary Autolus Therapeutics Plc (Autolus), formerly Autolus Therapeutics Limited is a clinical-stage biopharmaceutical company which offers programmed T cell immunotherapies for the treatment of hematological cancers and solid tumors. The company utilizes its T-cell programming and manufacturing te …
  • Novartis India Ltd (500672):企業の財務・戦略的SWOT分析
    Summary Novartis India Ltd (Novartis), a subsidiary of Novartis AG, is a healthcare company that offers pharmaceuticals, generic medicine and eye care products. The company’s pharmaceutical division develops drugs in the therapeutic areas of bone and pain, calcium portfolio, gynecology, oncology and …
  • Deoleo SA:企業の戦略・SWOT・財務分析
    Deoleo SA - Strategy, SWOT and Corporate Finance Report Summary Deoleo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • EBTEC Corporation:企業の戦略・SWOT・財務分析
    EBTEC Corporation - Strategy, SWOT and Corporate Finance Report Summary EBTEC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆